Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith H Keller

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of the American Society of Nephrology : JASN|January 22, 2022
Authors' ReplyAndrew J B Watts, Keith H Keller, Astrid Weins
Kidney International Reports|August 19, 2024
Clinical Characteristics of Nephrin Autoantibody-Positive Minimal Change Disease in Older AdultsYoko Fujita, Andrew J B Watts, Daisuke Ichikawa, et al.
Kidney International Reports|September 18, 2024
Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With PlasmapheresisIain Bressendorff, Karl Emil Nelveg-Kristensen, Maryam Ghasemi, et al.
Glomerular Diseases|February 24, 2025
Genetic and Iatrogenic Defects in Peripheral Tolerance Associated with Anti-Nephrin Antibody-Associated Minimal Change DiseaseJ Ashley Jefferson, Karin Chen, Sangeeta Hingorani, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2021
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune EtiologyAndrew J B Watts, Keith H Keller, Gabriel Lerner, et al.
The Journal of Clinical Investigation|December 16, 2024
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptorsSilvana Bazua-Valenti, Matthew R Brown, Jason Zavras, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of the American Society of Nephrology : JASN|January 22, 2022
Authors' ReplyAndrew J B Watts, Keith H Keller, Astrid Weins
Kidney International Reports|August 19, 2024
Clinical Characteristics of Nephrin Autoantibody-Positive Minimal Change Disease in Older AdultsYoko Fujita, Andrew J B Watts, Daisuke Ichikawa, et al.
Kidney International Reports|September 18, 2024
Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With PlasmapheresisIain Bressendorff, Karl Emil Nelveg-Kristensen, Maryam Ghasemi, et al.
Glomerular Diseases|February 24, 2025
Genetic and Iatrogenic Defects in Peripheral Tolerance Associated with Anti-Nephrin Antibody-Associated Minimal Change DiseaseJ Ashley Jefferson, Karin Chen, Sangeeta Hingorani, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2021
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune EtiologyAndrew J B Watts, Keith H Keller, Gabriel Lerner, et al.
The Journal of Clinical Investigation|December 16, 2024
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptorsSilvana Bazua-Valenti, Matthew R Brown, Jason Zavras, et al.
Pageof 1